Boston Scientific EBITDA 2010-2025 | BSX

Boston Scientific annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Boston Scientific EBITDA for the quarter ending March 31, 2025 was $1.137B, a 26.47% increase year-over-year.
  • Boston Scientific EBITDA for the twelve months ending March 31, 2025 was $4.260B, a 18.43% increase year-over-year.
  • Boston Scientific 2024 annual EBITDA was $4.26B, a 18.43% increase from 2023.
  • Boston Scientific 2023 annual EBITDA was $3.597B, a 23.4% increase from 2022.
  • Boston Scientific 2022 annual EBITDA was $2.915B, a 9.55% increase from 2021.
Boston Scientific Annual EBITDA
(Millions of US $)
2024 $4,260
2023 $3,597
2022 $2,915
2021 $2,661
2020 $1,577
2019 $2,633
2018 $2,435
2017 $2,133
2016 $1,273
2015 $505
2014 $619
2013 $1,285
2012 $1,307
2011 $2,339
2010 $2,042
2009 $-48
Boston Scientific Quarterly EBITDA
(Millions of US $)
2024-12-31 $1,137
2024-09-30 $1,039
2024-06-30 $1,107
2024-03-31 $977
2023-12-31 $899
2023-09-30 $993
2023-06-30 $869
2023-03-31 $836
2022-12-31 $695
2022-09-30 $767
2022-06-30 $696
2022-03-31 $757
2021-12-31 $667
2021-09-30 $787
2021-06-30 $570
2021-03-31 $637
2020-12-31 $421
2020-09-30 $265
2020-06-30 $284
2020-03-31 $607
2019-12-31 $209
2019-09-30 $383
2019-06-30 $384
2019-03-31 $541
2018-12-31 $318
2018-09-30 $389
2018-06-30 $391
2018-03-31 $408
2017-12-31 $319
2017-09-30 $377
2017-06-30 $225
2017-03-31 $364
2016-12-31 $140
2016-09-30 $348
2016-06-30 $-334
2016-03-31 $293
2015-12-31 $-227
2015-09-30 $-299
2015-06-30 $219
2015-03-31 $24
2014-12-31 $-493
2014-09-30 $64
2014-06-30 $-69
2014-03-31 $197
2013-12-31 $127
2013-09-30 $103
2013-06-30 $220
2013-03-31 $-330
2012-12-31 $117
2012-09-30 $-594
2012-06-30 $-3,587
2012-03-31 $196
2011-12-31 $171
2011-09-30 $174
2011-06-30 $237
2011-03-31 $322
2010-12-31 $348
2010-09-30 $251
2010-06-30 $231
2010-03-31 $-1,486
2009-12-31 $-1,231
2009-09-30 $51
2009-06-30 $275
2009-03-31 $11
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $152.152B $16.747B
Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $226.763B 27.35
Stryker (SYK) United States $142.721B 30.67
EssilorLuxottica (ESLOY) France $133.556B 0.00
Medtronic (MDT) Ireland $108.708B 15.87
Lonza Group Ag (LZAGY) Switzerland $51.613B 0.00
Haleon (HLN) United Kingdom $45.796B 26.03
ResMed (RMD) United States $34.691B 26.06
GE HealthCare Technologies (GEHC) United States $32.200B 15.29
Agilent Technologies (A) United States $30.677B 20.26
Terumo (TRUMY) Japan $28.397B 0.00
Koninklijke Philips (PHG) Netherlands $23.827B 17.01
Zimmer Biomet Holdings (ZBH) United States $20.388B 12.88
Insulet (PODD) United States $17.717B 75.76
Baxter (BAX) United States $15.988B 11.50
Smith & Nephew SNATS (SNN) United Kingdom $12.272B 0.00
Sunny Optical Technology (SNPTF) China $7.609B 0.00
Demant (WILYY) Denmark $7.600B 0.00
Lantheus Holdings (LNTH) United States $7.145B 17.57
Bio-Rad Laboratories (BIO) United States $6.837B 23.67
Prestige Consumer Healthcare (PBH) United States $4.024B 19.20
Perrigo (PRGO) Ireland $3.510B 10.05
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.362B 28.64
Haemonetics (HAE) United States $3.166B 14.90
Envista Holdings (NVST) United States $2.725B 22.03
GN Store Nord (GNNDY) Denmark $2.260B 18.72
LeMaitre Vascular (LMAT) United States $2.050B 46.77
QuidelOrtho (QDEL) United States $1.875B 15.70
AtriCure (ATRC) United States $1.480B 0.00
Green Thumb Industries (GTBIF) United States $1.401B 22.00
Kestra Medical Technologies (KMTS) United States $1.235B 0.00
AdaptHealth (AHCO) United States $1.148B 11.05
BioLife Solutions (BLFS) United States $1.145B 0.00
Neogen (NEOG) United States $1.096B 14.03
InMode (INMD) Israel $0.981B 8.98
Phibro Animal Health (PAHC) United States $0.754B 11.56
Evolus (EOLS) United States $0.735B 0.00
Curaleaf Holdings (CURLF) Canada $0.713B 0.00
Capricor Therapeutics (CAPR) United States $0.580B 0.00
CeriBell (CBLL) United States $0.577B 0.00
Owens & Minor (OMI) United States $0.545B 4.64
Valneva SE (VALN) France $0.531B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.514B 0.00
Tilray Brands (TLRY) Canada $0.488B 0.00
Cresco Labs (CRLBF) United States $0.479B 0.00
Omeros (OMER) United States $0.427B 0.00
Surmodics (SRDX) United States $0.400B 0.00
SNDL (SNDL) Canada $0.392B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.357B 0.00
VAREX IMAGING (VREX) United States $0.343B 14.86
Verano Holdings (VRNOF) United States $0.323B 0.00
Sanara MedTech (SMTI) United States $0.284B 0.00
Viemed Healthcare (VMD) United States $0.279B 25.25
Aurora Cannabis (ACB) Canada $0.261B 46.40
Canopy Growth (CGC) Canada $0.254B 0.00
Cerus (CERS) United States $0.252B 0.00
ZimVie (ZIMV) United States $0.252B 15.10
OraSure Technologies (OSUR) United States $0.232B 0.00
Sanuwave Health (SNWV) United States $0.231B 0.00
Quanterix (QTRX) United States $0.223B 0.00
High Tide (HITI) Canada $0.195B 0.00
Biote (BTMD) United States $0.182B 4.16
Utah Medical Products (UTMD) United States $0.170B 13.69
TriSalus Life Sciences (TLSI) United States $0.166B 0.00
Brainsway (BWAY) Israel $0.164B 51.00
Organigram Global (OGI) Canada $0.146B 0.00
Jin Medical (ZJYL) China $0.142B 0.00
FitLife Brands (FTLF) United States $0.142B 17.46
TerrAscend (TSNDF) Canada $0.128B 0.00
Agape ATP (ATPC) $0.115B 0.00
Exagen (XGN) United States $0.112B 0.00
MacroGenics (MGNX) United States $0.109B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.095B 0.00
Quipt Home Medical (QIPT) United States $0.093B 0.00
Jushi Holdings (JUSHF) United States $0.082B 0.00
Veru (VERU) United States $0.079B 0.00
Fonar (FONR) United States $0.078B 10.91
InterCure (INCR) Israel $0.072B 0.00
United Health Products (UEEC) United States $0.065B 0.00
Cytosorbents (CTSO) United States $0.063B 0.00
Zynex (ZYXI) United States $0.050B 0.00
ImmuCell (ICCC) United States $0.049B 0.00
Modular Medical (MODD) United States $0.044B 0.00
Apyx Medical (APYX) United States $0.039B 0.00
Safety Shot (SHOT) United States $0.039B 0.00
Rockwell Medical (RMTI) United States $0.037B 54.00
United-Guardian (UG) United States $0.036B 11.14
Nephros (NEPH) United States $0.021B 0.00
INLIF (INLF) $0.018B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Flora Growth (FLGC) United States $0.011B 0.00
Allurion Technologies (ALUR) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.007B 0.00
Innovative Eyewear (LUCY) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Senestech (SNES) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00